Health Trials

About this trial

The neurolytic blocks of sympathetic chains are commonly used for the treatment of cancer-related pain. This study aims to compare celiac plexus neurolysis and splanchnic nerve neurolysis for the treatment of abdominal visceral pain and its influence on the quality of life of patients with cancer.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Splanchnic nerve neurolysis - 5 ml of absolute alcohol (100%)
  • Celiac Plexus Neurolysis - 5 ml of absolute alcohol (100%)

Treatment groups

64 Participants
are divided into 2 treatment groups

Locations

1
Instituto de Cancer Do Estado01246-000, São PauloSão Paulo, Brazil

Sponsors and collaborators

Instituto do Cancer do Estado de São Paulo

Lead sponsor

Source ClinicalTrials.gov